Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept
A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mylan NV
Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia
Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…